Venture Philanthropy EBRP uses a venture philanthropy model that generates recurring donation streams from successful therapies, presenting a potential co-investment and sponsorship angle for funders, biotech partners, and grantmaking networks seeking scalable impact.

Research Funding Scale With a revenue range of 10 to 25 million and a focus on funding EB research, there is opportunity to pursue strategic partnerships, multi-year grants, and philanthropic campaigns with corporations and family offices seeking aligned health-focused CSR initiatives.

Strategic Partnerships History of collaborations with biotech companies (eg ProQR) and cross-sector partners suggests openness to joint ventures, milestone-based funding, and co-branded programs that accelerate EB therapies toward clinical use.

Awareness and Media Recent press and partnerships (Gw Giants, digitalMusicNews) indicate growing visibility; leverage media partnerships for sponsored awareness campaigns, donor recruitment drives, and branded advocacy events to expand donor base.

Global Impact Footprint As the largest nonprofit focused on EB, EBRP has a broad stakeholder network across researchers, patient communities, and industry; target B2B introductions to pharmaceutical, contract research organizations, and patient advocacy coalitions to unlock collaborative funding and research opportunities.